Time Is On Eisai’s Side As More Long-Term Data Emerge For Leqembi

Dual Action Stands Out From Lilly’s Kisunla

 
• By Mandy Jackson
  
Caregiver cheers up senior lady patient touching hand while sits in armchairs in light room
Maintenance and subcutaneous dosing could reduce the burden of chronic Leqembi treatment • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D